Previous Close | 85.66 |
Open | 85.62 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 84.90 - 86.90 |
52 Week Range | 77.40 - 127.68 |
Volume | |
Avg. Volume | 408,668 |
Market Cap | 16.857B |
Beta (5Y Monthly) | 0.60 |
PE Ratio (TTM) | 21.32 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.68 (0.81%) |
Ex-Dividend Date | Jul 01, 2021 |
1y Target Est | N/A |
LUXEMBOURG, May 24, 2022--Eurofins (Paris:ERF): Eurofins Environment Testing laboratories in Sacramento, CA and Lancaster, PA announce that they have received accreditation for Draft EPA Method 1633 for the US Department of Defense under QSM 5.4 Table B-24 for all 40 PFAS compounds for water, solids and tissue matrices. These laboratories are some of the first commercial laboratories to receive this accreditation, further exemplifying the Eurofins network of laboratories as a leader in PFAS test
LUXEMBOURG, May 10, 2022--Eurofins CDMO Alphora Inc. announces receipt in April 2022 of its Health Canada Standard Processing License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario Operations. This is complementary to the Institutional Research License obtained through Health Canada in June 2021 for its Mississauga development site.
LUXEMBOURG, May 09, 2022--Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing, announces that it has successfully signed an agreement with Stichting PAMM Laboratoria voor Pathologie en Medische Microbiologie ("PAMM"), a medical microbiology and pathology laboratory diagnostics company in The Netherlands.